Terrasil Eczema And Psoriasis
Thuja Occidentalis, Symphytum Officinale
Aidance Skincare & Topical Solutions, Llc
Human Otc Drug
NDC 24909-167Terrasil Eczema And Psoriasis also known as Thuja Occidentalis, Symphytum Officinale is a human otc drug labeled by 'Aidance Skincare & Topical Solutions, Llc'. National Drug Code (NDC) number for Terrasil Eczema And Psoriasis is 24909-167. This drug is available in dosage form of Kit. The names of the active, medicinal ingredients in Terrasil Eczema And Psoriasis drug includes . The currest status of Terrasil Eczema And Psoriasis drug is Active.
Drug Information:
| Drug NDC: | 24909-167 |
| The labeler code and product code segments of the National Drug Code number, separated by a hyphen. Asterisks are no longer used or included within the product code segment to indicate certain configurations of the NDC. |
| Proprietary Name: | Terrasil Eczema And Psoriasis |
| Also known as the trade name. It is the name of the product chosen by the labeler. |
| Product Type: | Human Otc Drug |
| Indicates the type of product, such as Human Prescription Drug or Human OTC Drug. This data element corresponds to the “Document Type” of the SPL submission for the listing. |
| Non Proprietary Name: | Thuja Occidentalis, Symphytum Officinale |
| Also known as the generic name, this is usually the active ingredient(s) of the product. |
| Labeler Name: | Aidance Skincare & Topical Solutions, Llc |
| Name of Company corresponding to the labeler code segment of the ProductNDC. |
| Dosage Form: | Kit |
| The translation of the DosageForm Code submitted by the firm. There is no standard, but values may include terms like `tablet` or `solution for injection`.The complete list of codes and translations can be found www.fda.gov/edrls under Structured Product Labeling Resources. |
| Status: | Active |
| FDA does not review and approve unfinished products. Therefore, all products in this file are considered unapproved. |
| Substance Name: | |
| This is the active ingredient list. Each ingredient name is the preferred term of the UNII code submitted. |
| Route Details: | |
| The translation of the Route Code submitted by the firm, indicating route of administration. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
Marketing Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Marketing Category: | UNAPPROVED HOMEOPATHIC |
| Product types are broken down into several potential Marketing Categories, such as New Drug Application (NDA), Abbreviated New Drug Application (ANDA), BLA, OTC Monograph, or Unapproved Drug. One and only one Marketing Category may be chosen for a product, not all marketing categories are available to all product types. Currently, only final marketed product categories are included. The complete list of codes and translations can be found at www.fda.gov/edrls under Structured Product Labeling Resources. |
| Marketing Start Date: | 20 Apr, 2016 |
| This is the date that the labeler indicates was the start of its marketing of the drug product. |
| Marketing End Date: | 19 Jun, 2026 |
| This is the date the product will no longer be available on the market. If a product is no longer being manufactured, in most cases, the FDA recommends firms use the expiration date of the last lot produced as the EndMarketingDate, to reflect the potential for drug product to remain available after manufacturing has ceased. Products that are the subject of ongoing manufacturing will not ordinarily have any EndMarketingDate. Products with a value in the EndMarketingDate will be removed from the NDC Directory when the EndMarketingDate is reached. |
| Listing Expiration Date: | 31 Dec, 2023 |
| This is the date when the listing record will expire if not updated or certified by the firm. |
OpenFDA Information:
An openfda section: An annotation with additional product identifiers, such as NUII and UPC, of the drug product, if available.
| Manufacturer Name: | Aidance Skincare & Topical Solutions, LLC
|
| Name of manufacturer or company that makes this drug product, corresponding to the labeler code segment of the NDC. |
| Original Packager: | Yes
|
| Whether or not the drug has been repackaged for distribution. |
| UNII: | |
| Unique Ingredient Identifier, which is a non-proprietary, free, unique, unambiguous, non-semantic, alphanumeric identifier based on a substance’s molecular structure and/or descriptive information. |
Packaging Information:
| Package NDC | Description | Marketing Start Date | Marketing End Date | Sample Available |
|---|
| 24909-167-99 | 1 KIT in 1 PACKAGE, COMBINATION (24909-167-99) * 85 g in 1 TUBE (24909-177-85) * 28 g in 1 TUBE (24909-187-28) | 20 Apr, 2016 | N/A | No |
| Package NDC number, known as the NDC, identifies the labeler, product, and trade package size. The first segment, the labeler code, is assigned by the FDA. Description tells the size and type of packaging in sentence form. Multilevel packages will have the descriptions concatenated together. |
Purpose:
Purpose thuja occidentalis - eczema & psoriasis relief / dry skin relief symphytum officinale (comfrey) - inflammatory relief
Product Elements:
Terrasil eczema and psoriasis thuja occidentalis, symphytum officinale terrasil eczema and psoriasis daily care thuja occidentalis, symphytum officinale thuja occidentalis leafy twig thuja occidentalis leafy twig symphytum officinale whole symphytum officinale whole white wax cottonseed oil cetostearyl alcohol polysorbate 60 jojoba oil garcinia indica seed butter magnesium oxide peppermint oil shea butter silver oxide sorbic acid zinc oxide terrasil eczema and psoriasis severe outbreak thuja occidentalis, symphytum officinale thuja occidentalis leafy twig thuja occidentalis leafy twig symphytum officinale whole symphytum officinale whole bentonite cottonseed oil jojoba oil magnesium oxide peppermint oil silver oxide white wax zinc oxide
Indications and Usage:
Uses to relieve symptoms associated with eczema, psoriasis, and severe dry, itchy and flaky skin.
Warnings:
Warnings for external use only avoid contact with eyes. if symptoms persist for more than seven days, discontinue use and consult a physician. if pregnant or breast feeding , contact a physician prior to use. keep out of reach of children. if swallowed, consult a physician.
Dosage and Administration:
Directions severe outbreak ointment: massage a small amount into affected skin. reapply up to 4 times daily. store at room temperature. may stain fabrics. daily care cream: massage into affected skin. reapply up to 4 times daily. store at room temperature.
Package Label Principal Display Panel:
Principal display panel - box eczema & psoriasis 2 tube system all natural terrasil 1 > daily care cream 2 > severe outbreak ointment patented medical technology 3x triple action formula - fast & effective relief box